Search for: "State v. Gray" Results 801 - 820 of 1,841
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Feb 2010, 11:45 am
U.S. 1st Circuit Court of Appeals, January 25, 2010 Gray v. [read post]
8 Feb 2010, 11:45 am
U.S. 1st Circuit Court of Appeals, January 25, 2010 Gray v. [read post]
2 Apr 2016, 12:20 pm
  Robert GoldmanRobert Goldman (Ropes & Gray) stated that the issues at trial are more equitable than economic. [read post]
18 Feb 2022, 10:45 pm by Florian Mueller
One day after the United States International Trade Commission ("USITC" or just "ITC") instituted three investigations further to Ericsson v. [read post]
2 May 2022, 10:53 am by Mark J. Levin
  Affirming the district court, the appeals court held that the plaintiffs in Berman v. [read post]
26 Mar 2010, 8:21 am by Lawrence B. Ebert
**Separately, of gray literature, from E. [read post]
5 Mar 2009, 6:30 am
This is the third in the four-part series from the brain injury case of Gregory Joseph Gagnon, et al. v. [read post]
28 Jun 2022, 4:38 am by Charles Sartain
Co-author Carolina Cuppitelli* The question presented in Aaron v. [read post]
7 Jul 2010, 5:14 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) - EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat)   General An… [read post]
6 Jul 2010, 6:03 pm by Duncan
  Highlights this week included: Biotechnology patents: Court of Justice of the EU decides against patent theory of Monsanto: Monsanto v Cefetra & Ors (BLOG@IP::JUR) (EPLAW) (IPKat) Prilosec / Losec (Omeprazole) – EU: General Court largely upholds European Commission decision in AstraZeneca v Commission (EPLAW) (IPKat)   General An overview of the ‘Health Impact Fund’ model for accessible medicines (Spicy IP) Pharma pay-and-procure symposium (IP… [read post]